Duke Robotics Corp. is at the forefront of revolutionizing medical surgical procedures through its pioneering robotic technology platform tailored for minimally invasive and remote surgeries. By integrating advanced robotics with artificial intelligence and machine learning, the company enhances surgical precision, operational efficiency, and patient outcomes in healthcare environments. As the global demand for innovative surgical solutions escalates, Duke Robotics is strategically positioned to lead the robotic-assisted surgery market, driven by its robust commitment to research and development. This focus on innovation not only addresses the evolving needs of healthcare professionals but also significantly improves patient care in an increasingly complex medical landscape.
| Revenue (TTM) | 377,000 |
| Gross Profit (TTM) | 154,000 |
| EBITDA | $-1.35M |
| Operating Margin | -379.60% |
| Return on Equity | -41844.00% |
| Return on Assets | -72.70% |
| Revenue/Share (TTM) | $0.17 |
| Book Value | $-0.25 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -50.00% |
| Shares Outstanding | 0 |
| Float | $2.19M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on DUKRW and any ticker you trade — then tracks every position and per-strategy win rate.